RELYPSA

relypsa-logo

Relypsa, Inc. is a privately-held, development stage biopharmaceutical company leading the discovery and development of novel non-absorbed polymeric drugs for important applications in cardiovascular and renal disease. Relypsa's lead product candidate is RLY5016, a non-absorbed potassium binder for the management of hyperkalemia. Relypsa is dedicated to discover additional product candidates through use of its proprietary polymer platform.

#People #Financial #Website #More

RELYPSA

Social Links:

Industry:
Biopharma Biotechnology Health Care

Founded:
2007-10-01

Address:
Redwood City, California, United States

Country:
United States

Website Url:
http://www.relypsa.com

Total Employee:
501+

Status:
Closed

Contact:
(650) 421-9500

Email Addresses:
[email protected]

Total Funding:
656.63 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Domain Not Resolving Mobile Non Scaleable Content Microsoft Azure DNS DigiCert SSL ASP.NET 4.0 ASP.NET Ajax RapidSSL



Current Advisors List

deepika-r-pakianathan_image

Deepika R Pakianathan Board Observer @ Relypsa
Board_observer

klaus-veitinger_image

Klaus Veitinger Vice Chairman @ Relypsa
Board_member

scott-m-rocklage_image

Scott M. Rocklage Board Chairman @ Relypsa
Board_member

vijay-lathi_image

Vijay Lathi Board Director @ Relypsa
Board_member

david-mcgirr_image

David McGirr Board Member @ Relypsa
Board_member

kevin-forrest_image

Kevin Forrest Board Observer @ Relypsa
Board_observer

jonathan-silverstein_image

Jonathan Silverstein Member of the Board of Directors @ Relypsa
Board_member

Current Employees Featured

eric-roul_image

Eric Roul
Eric Roul Associate Director IT Helpdesk & PMO @ Relypsa
Associate Director IT Helpdesk & PMO
2019-10-01

mary-e-corbett_image

Mary E Corbett
Mary E Corbett Senior Vice President of Human Resources @ Relypsa
Senior Vice President of Human Resources
2013-12-01

eric-roul_image

Eric Roul
Eric Roul Sr IT Project Manager @ Relypsa
Sr IT Project Manager
2018-09-01

patrick-treanor_image

Patrick Treanor
Patrick Treanor President @ Relypsa
President

Founder


gerrit-klaerner_image

Gerrit Klaerner

Stock Details


Company's stock symbol is NASDAQ:RLYP

Investors List

oxford-finance-corporation_image

Oxford Finance LLC

Oxford Finance LLC investment in Post-IPO Debt - Relypsa

silicon-valley-bank_image

Silicon Valley Bank

Silicon Valley Bank investment in Post-IPO Debt - Relypsa

orbimed-advisors_image

OrbiMed

OrbiMed investment in Venture Round - Relypsa

5am-ventures_image

5AM Ventures

5AM Ventures investment in Venture Round - Relypsa

new-leaf-venture-partners_image

New Leaf Venture Partners

New Leaf Venture Partners investment in Venture Round - Relypsa

new-leaf-venture-partners_image

New Leaf Venture Partners

New Leaf Venture Partners investment in Series C - Relypsa

delphi-ventures_image

Delphi Ventures

Delphi Ventures investment in Series C - Relypsa

sibling-capital_image

Sibling Capital

Sibling Capital investment in Series C - Relypsa

the-sprout-group_image

Sprout Group

Sprout Group investment in Series C - Relypsa

mediphase-venture-partners_image

Mediphase Venture Partners

Mediphase Venture Partners investment in Series C - Relypsa

Official Site Inspections

http://www.relypsa.com

  • Host name: ewhserver1302.edgewebhosting.net
  • IP address: 69.63.140.80
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Relypsa"

Relypsa - Crunchbase Company Profile & Funding

Relypsa is a biotech company. They discover and develop non-absorbed polymeric drugs for applications in cardiovascular and renal diseases. They specialize in iron deficiency, …See details»

Relypsa Company Profile 2024: Valuation, Investors, …

Operator of a biopharmaceutical company based in Redwood City, California. The company is focused on the discovery, development and commercialization of polymeric medicines for patients with conditions that are overlooked and …See details»

Relypsa Company Profile - Office Locations, Competitors ... - Craft

Relypsa is dedicated to discovering additional product candidates through use of its proprietary polymer platform. See insights on Relypsa including office locations, competitors, revenue, …See details»

Relypsa Inc. - In Vivo

Key Ilypsa employees and investors wanted to carry out those programs, and with Amgen's blessing, they moved swiftly to form Relypsa Inc., which retains rights to Ilypsa's remaining …See details»

Relypsa - VentureRadar

Website: http://www.relypsa.com Develops novel non-absorbed polymeric drugs for cardiovascular and renal diseases, with lead product candidate patiromer targeting …See details»

Relypsa - Products, Competitors, Financials, Employees, …

Jul 8, 2016 · Relypsa is a clinical-stage biopharmaceutical company leading the discovery and development of non-absorbed polymeric drugs for applications in cardiovascular and renal disease. Relypsa's lead product candidate is …See details»

Relypsa, Inc. - Redwood City, USA - bionity.com

Aug 12, 2015 · Relypsa, Inc. is a publicly traded, biopharmaceutical company focused on the development and commercialization of non-absorbed polymeric drugs to treat disorders in the …See details»

Galenica completes acquisition of Relypsa, strengthening Vifor …

Sep 2, 2016 · Galenica Group today announced that it has completed its previously announced acquisition of Relypsa, Inc., (RLYP).See details»

Relypsa - Contacts, Employees, Board Members, Advisors & Alumni

Relypsa is a biopharmaceutical company developing drugs for treating cardiovascular and renal diseases.See details»

Galenica to buy biotech firm Relypsa for $1.5 billion, ahead of split

Jul 21, 2016 · Galenica has agreed to buy Relypsa for $1.53 billion, paying a big premium for the Californian biotech company to strengthen its Vifor Pharma unit ahead …See details»

Relypsa | Scientist.com

Relypsa, Inc. is a privately-held, clinical-stage pharmaceutical company focused on the development and commercialization of nonabsorbed polymeric drugs to treat disorders in the …See details»

PRESS RELEASE: Relypsa Formed With $33 Million Series A …

Oct 30, 2007 · Relypsa, Inc. is a biopharmaceutical company leading the discovery and development of new non-absorbed polymeric drugs for important applications in renal and …See details»

Galenica To Acquire Relypsa For $32 A Share - Yahoo Finance

Jul 21, 2016 · Galenica Group and Relypsa Inc (NYSE: RLYP ) revealed that they reached a definitive agreement by which the former would acquire Relypsa for $32.00 a share or a total …See details»

Relypsa CEO and Key Executive Team | Craft.co

Relypsa's key executives include Patrick Treanor and 8 others. Need Data? Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API. …See details»

Relypsa, Inc. Announces Appointment of John Orwin as CEO

May 17, 2013 · Relypsa, Inc. is a late clinical-stage biopharmaceutical company leading the discovery and development of novel non-absorbed polymeric drugs for important applications …See details»

Swiss group Galencia buys US biotech Relypsa for $1.5 billion

Jul 21, 2016 · Swiss healthcare group Galencia will pay $1.53 billion to acquire the U.S. biotech Relypsa, maker of a recently approved drug for hyperkalemia, the companies announced …See details»

Relypsa finally finds a buyer as Veltassa partner Galenica coughs …

Jul 21, 2016 · After a year of takeover rumors that seemed to fizzle out into nothing, Relypsa has finally found its match in the biotech’s drug marketing partner and Swiss healthcare company …See details»

Relypsa, Inc Careers and Employment | Indeed.com

Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for popular roles and read about the team’s work-life balance. Uncover why Relypsa, Inc is the …See details»

Relypsa Reviews: What Is It Like to Work At Relypsa?

22 Relypsa reviews. A free inside look at company reviews and salaries posted anonymously by employees.See details»

Relypsa Reviews: What Is It Like to Work At Relypsa? - Glassdoor

Relypsa has an overall rating of 3.2 out of 5, based on over 26 reviews left anonymously by employees. 42% of employees would recommend working at Relypsa to a friend and 36% …See details»

linkstock.net © 2022. All rights reserved